Lotte Knudsen, who pushed Novo Nordisk into the Ozempic era, wins STAT Innovation award
STAT
OCTOBER 18, 2023
Back in the 1990s, scientist Lotte Bjerre Knudsen was tasked with revitalizing a floundering program at Novo Nordisk that had been trying to harness the newly-discovered GLP-1 hormone into viable diabetes drug candidates. At the time, many of Knudsen’s bosses had already lost hope for the program.
Let's personalize your content